lunes, 6 de octubre de 2025

Skye’s obesity drug fails in mid-stage study Data raise questions about a similar treatment in development by Novo Nordisk

https://www.statnews.com/2025/10/06/skye-cb1-weight-loss-obesity-drugs-novo-nordisk-nimacimab/

No hay comentarios: